En savoir plus sur le livre
Acclaimed by the worldwide medical community as "the ultimate authority on cancer" (JAMA), Cancer: Principles and Practice of Oncology is now in its Seventh Edition. This completely revised, updated classic reflects the latest breakthroughs in molecular biology, cancer prevention, and multimodality treatment of every cancer type. New chapters examine molecular biologic techniques including proteomics, genomics, targeted therapies, RNA interference, cDNA arrays, and tissue arrays. New sections discuss bioinformatics and societal issues in oncology, including regulatory issues, telemedicine, and international differences in oncology. Coverage also includes new information on functional and metabolic imaging, vaccines, and antiangiogenesis agents.
Achat du livre
Cancer. Principles and Practice of Oncology. vol. 1., Collectif d'auteurs
- Langue
- Année de publication
- 1997
- product-detail.submit-box.info.binding
- (rigide)
Modes de paiement
Personne n'a encore évalué .
- Titre
- Cancer. Principles and Practice of Oncology. vol. 1.
- Langue
- Anglais
- Auteurs
- Collectif d'auteurs
- Éditeur
- Lippincott
- Publié
- 1997
- Format
- rigide
- Pages
- 1712
- ISBN10
- 039751574X
- ISBN13
- 9780397515745
- Séries
- Mots clés
- Nonfiction, Santé & Médecine, Médecine
- Description
- Acclaimed by the worldwide medical community as "the ultimate authority on cancer" (JAMA), Cancer: Principles and Practice of Oncology is now in its Seventh Edition. This completely revised, updated classic reflects the latest breakthroughs in molecular biology, cancer prevention, and multimodality treatment of every cancer type. New chapters examine molecular biologic techniques including proteomics, genomics, targeted therapies, RNA interference, cDNA arrays, and tissue arrays. New sections discuss bioinformatics and societal issues in oncology, including regulatory issues, telemedicine, and international differences in oncology. Coverage also includes new information on functional and metabolic imaging, vaccines, and antiangiogenesis agents.